Results 31 to 40 of about 108,334 (250)
Impact analysis of heart failure across European countries: an ESC‐HFA position paper
ESC Heart Failure, Volume 9, Issue 5, Page 2767-2778, October 2022., 2022 Abstract
Heart failure (HF) is a long‐term clinical syndrome, with increasing prevalence and considerable healthcare costs that are further expected to increase dramatically. Despite significant advances in therapy and prevention, mortality and morbidity remain high and quality of life poor.Giuseppe M.C. Rosano, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Yuri Lopatin, Fin Gustafsson, Antoni Bayes‐Genis, Tiny Jaarsma, Magdy Abdelhamid, Arantxa Gonzalez Miqueo, Massimo Piepoli, Carlo G. Tocchetti, Arsen D. Ristić, Ewa Jankowska, Brenda Moura, Loreena Hill, Gerasimos Filippatos, Marco Metra, Davor Milicic, Thomas Thum, Ovidiu Chioncel, Tuvia Ben Gal, Lars H. Lund, Dimitrios Farmakis, Wilfried Mullens, Stamatis Adamopoulos, Michael Bohm, Anna Norhammar, Andreas Bollmann, Amitava Banerjee, Aldo P. Maggioni, Adriaan Voors, Alain Cohen Solal, Andrew J.S. Coats +33 morewiley +1 more sourceCorrelações entre variáveis respiratórias e funcionais na insuficiência cardíaca
Revista Portuguesa de Pneumologia, 2009 AbstractBackground: Respiratory alterations can impact on the functional performance of patients with heart failure.Aim: To correlate maximum inspiratory muscular force and lung function variables with functional capacity in heart failure patients.Methods: A transversal study January-July 2007 with 42 chronic heart disease patients (28 males) with no ...Naso, Fábio Cangeri Di, Pereira, Juliana Saraiva, Dias, Alexandre Simões, Forgiarini Junior, Luiz Alberto, Monteiro, Mariane Borba +4 moreopenaire +5 more sourcesDapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
European Journal of Heart Failure, Volume 24, Issue 10, Page 1892-1901, October 2022., 2022 Summary of clinical profiles and treatment effects of dapagliflozin by baseline New York Heart Association (NYHA) class, as well as the impact of dapagliflozin on changes in NYHA class over time in this pre‐specified analysis of the DELIVER trial. CI, confidence interval; DELIVER, Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved John W. Ostrominski, Muthiah Vaduganathan, Brian L. Claggett, Rudolf A. de Boer, Akshay S. Desai, Dan Dobreanu, Adrian F. Hernandez, Silvio E. Inzucchi, Pardeep S. Jhund, Mikhail Kosiborod, Carolyn S.P. Lam, Anna M. Langkilde, Daniel Lindholm, Felipe A. Martinez, Eileen O'Meara, Magnus Petersson, Sanjiv J. Shah, Jorge Thierer, John J.V. McMurray, Scott D. Solomon +19 morewiley +1 more sourceAtualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021
Arquivos Brasileiros de Cardiologia, 2021 Autores da Diretriz: Fabiana G. Marcondes-Braga,1 Lídia Ana Zytynski Moura,2 Victor Sarli Issa,3 Jefferson Luis Vieira,4 Luis Eduardo Rohde,5,6,7 Marcus Vinícius Simões,8 Miguel Morita Fernandes-Silva,9,10 Salvador Rassi,11 Silvia Marinho Martins Alves ...F. G. Marcondes-Braga, Lídia Ana Zytynski Moura, V. Issa, J. Vieira, L. Rohde, M. Simões, M. M. Fernandes-Silva, S. Rassi, Sílvia Marinho Martins Alves, D. Albuquerque, D. Almeida, E. Bocchi, F. Ramires, F. Bacal, J. R. Rossi Neto, L. C. Danzmann, M. W. Montera, Múcio Tavares de Oliveira Júnior, N. Clausell, O. Silvestre, R. Bestetti, Sabrina Bernadez-Pereira, A. Freitas, A. Biolo, A. Barretto, Antônio José Lagoeiro Jorge, Bruno Biselli, C. Montenegro, Edval Gomes Dos Santos Júnior, E. Figueiredo, F. Fernandes, F. S. Silveira, F. Atik, F. Brito, G. Souza, Gustavo Calado de Aguiar Ribeiro, H. Villacorta, João David de Souza Neto, L. Goldraich, L. Beck-da-Silva, M. Canesin, M. I. Bittencourt, M. Bonatto, M. D. C. Moreira, M. Avila, O. R. Coelho Filho, P. Schwartzmann, R. Mourilhe-Rocha, S. Mangini, S. Ferreira, J. A. F. Figueiredo Neto, E. Mesquita +51 moresemanticscholar +1 more sourceImpact of SARS‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Volume 9, Issue 4, Page 2189-2198, August 2022., 2022 Abstract Aims
To describe the natural history of SARS‐CoV‐2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events. Methods and results
Three hundred and five patients [age 56.6 ± 16.9 years old, 191 (62.6%) male patients] with HCM and SARS‐Cov‐2 infection were enrolled ...Juan R. Gimeno, Iacopo Olivotto, Ana Isabel Rodríguez, Carolyn Y. Ho, Adrián Fernández, Alejandro Quiroga, Mari Angeles Espinosa, Cristina Gómez‐González, María Robledo, Lucas Tojal‐Sierra, Sharlene M. Day, Anjali Owens, Roberto Barriales‐Villa, Jose María Larrañaga, Jose Rodríguez‐Palomares, Maribel González‐del‐Hoyo, Jesús Piqueras‐Flores, Nosheen Reza, Olga Chumakova, Euan A. Ashley, Victoria Parikh, Matthew Wheeler, Daniel Jacoby, Alexandre C. Pereira, Sara Saberi, Adam S. Helms, Eduardo Villacorta, María Gallego‐Delgado, Daniel de Castro, Fernando Domínguez, Tomás Ripoll‐Vera, Esther Zorio‐Grima, José Carlos Sánchez‐Martínez, Ana García‐Álvarez, Elena Arbelo, María Victoria Mogollón, María Eugenia Fuentes‐Cañamero, Elias Grande, Carlos Peña, Lorenzo Monserrat, Neal K. Lakdawala, Dilema International Cardiomyopathy and Heart Failure Registry and international SHaRe (Sarcomeric Human Cardiomyopathy Registry) Investigators group, Carmen Muñoz‐Esparza, José Manuel García‐Pinilla, Ainhoa Robles‐Mezcua, María Victoria Moreno‐Flores, María Luisa Peña, Marco Merlo, David Vaqueriza Cubillo, Vicente Climent‐Payá, Elena Dankovtseva, Alejandro Rodríguez Vilela, Pablo García‐Pavía, Guillem Casas +53 morewiley +1 more sourceDOAÇÃO DE ÓRGÃOS SOB A ÓPTICA DO ESTUDANTE UNIVERSITÁRIO
Brazilian Journal of Transplantation, 2005
Objetivo: Conhecer a opinião dos estudantes universitários sobre a doação de órgãos. Método: Estudo exploratório-descritivo, realizado numa universidade privada, com 269 estudantes de idade igual ou superior a 18 anos.Zélia Maria de Sousa Araújo Santos, Arícia Pereira Capistrano, Vera Lúcia Mendes Oliveira, João David de Souza Neto +3 moredoaj +1 more sourceCalidad de vida de portadores de insuficiencia cardíaca [PDF]
, 2008 OBJETIVO: Identificar o nível de qualidade de vida de portadores de insuficiência cardíaca; o grau de insuficiência cardíaca dos pacientes; a opinião dos portadores de insuficiência cardíaca quanto ao seu estado de saúde atual quanto comparada há um ano ...GALDEANO, Luzia Elaine, LIMA, Rosilda Maria Beserra, SANTOS, Luciana Farias dos, SOARES, Djanira Alzira, TOLEDO, Jucimari Aparecida de Souza +4 morecore +2 more sourcesDistribuição Espacial de Mortalidade por Insuficiência Cardíaca no Brasil, 1996-2017
Arquivos Brasileiros de Cardiologia, 2021 Resumo Fundamento Insuficiência cardíaca (IC) é uma das principais causas de mortalidade e morbidade no mundo, e está associada ao alto uso de recursos e custos com saúde.V. Cestari, T. S. Garces, G. J. B. Sousa, T. A. Maranhão, João David de Souza Neto, M. L. D. Pereira, V. Pessoa, João Tobias Lima Sales, R. Florêncio, Lorena Campos de Souza, G. Vasconcelos, M. G. Sobral, Lara Lídia Ventura Damasceno, T. M. Moreira +13 moresemanticscholar +1 more sourceA comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry
European Journal of Heart Failure, Volume 24, Issue 2, Page 335-350, February 2022., 2022 Acute heart failure in patients with preserved (HFpEF), mildly reduced (HFmrEF) and reduced ejection fraction (HFrEF): admission profiles, in‐hospital treatment and outcomes. Aims
To perform a comprehensive characterization of acute heart failure (AHF) with preserved (HFpEF), versus mildly reduced (HFmrEF) versus reduced ejection fraction (HFrEF ...Agnieszka Kapłon‐Cieślicka, Lina Benson, Ovidiu Chioncel, Maria G. Crespo‐Leiro, Andrew J.S. Coats, Stefan D. Anker, Gerasimos Filippatos, Frank Ruschitzka, Camilla Hage, Jarosław Drożdż, Petar Seferovic, Giuseppe M.C. Rosano, Massimo Piepoli, Alexandre Mebazaa, Theresa McDonagh, Mitja Lainscak, Gianluigi Savarese, Roberto Ferrari, Aldo P. Maggioni, Lars H. Lund, on behalf of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long‐Term Registry Investigators +20 morewiley +1 more source